Table 1 SFMBT1 and HMG20A protein level and clinic parameters in 65 patients with colon cancer.
From: SFMBT1 facilitates colon cancer cell metastasis and drug resistance combined with HMG20A
Protein name | SFMBT1 | HMG20A | |||
|---|---|---|---|---|---|
Characteristics | All cases | Low | High | Low | High |
Participants | 65 | 28 | 37 | 30 | 35 |
Age (years) | |||||
<60 | 22 | 10 | 12 | 8 | 14 |
≥60 | 43 | 18 | 25 | 16 | 27 |
Gender | |||||
Male | 35 | 16 | 19 | 15 | 20 |
Female | 30 | 15 | 15 | 12 | 18 |
clinical stage | |||||
1–2 | 42 | 20 | 22 | 15 | 27 |
3–4 | 23 | 8 | 15 | 11 | 12 |
Tumor size (mm3) | |||||
<30 | 26 | 12 | 14 | 12 | 14 |
≥30 | 39 | 20 | 19 | 21 | 18 |
Lymphnode metastasis | |||||
Negative | 43 | 21 | 22 | 17 | 26 |
Positive | 22 | 6 | 16 | 10 | 12 |
